 |
 |
|
|
|
Practice-changing cancer studies presented at major cancer meeting
Fairfax, VA
Wednesday, October 28, 2009
The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.
News briefing 1
When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
• Additional, specialized radiation not necessary for some women after
mastectomy.
• Radiation after surgery reduces chance of melanoma returning.
• What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117037132&RG=1&UID=0&RT=MiM3
News briefing 2
When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Stereotactic radiotherapy stops lung cancer from growing in frail
patients.
• Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117046102&RG=1&UID=0&RT=MiM3
News briefing 3
When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Adding proton therapy "boost" to X-ray radiation therapy reduces prostate cancer recurrences.
• Proton therapy is well-tolerated in prostate cancer patients.
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117046192&RG=1&UID=0&RT=MiM3
News briefing 4
When: Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Shorter radiation course stops cancer growth in high-risk prostate cancer
patients.
• Shorter radiation course as effective as standard therapy for prostate cancer recurrence.
Where: McCormick Place West, Room 176b/c, or on the Web at https://astro.webex.com/astro/j.php?ED=117047452&RG=1&UID=0&RT=MiM3
How: To participate in the webcasts, click on the links above to view slides and listen to the audio of the conference live over the Internet.
Contact: Call the ASTRO Press Room at 312-791-7005 from November 1-4, or e-mail Beth Bukata at bethb@astro.org or Nicole Napoli at nicolen@astro.org. After hours, please call 703-474-0940.
###
News briefing 1
When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
• Additional, specialized radiation not necessary for some women after
mastectomy.
• Radiation after surgery reduces chance of melanoma returning.
• What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117037132&RG=1&UID=0&RT=MiM3
News briefing 2
When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Stereotactic radiotherapy stops lung cancer from growing in frail
patients.
• Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117046102&RG=1&UID=0&RT=MiM3
News briefing 3
When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Adding proton therapy "boost" to X-ray radiation therapy reduces prostate cancer recurrences.
• Proton therapy is well-tolerated in prostate cancer patients.
Where: McCormick Place West, Room 176b/c or on the Web at
https://astro.webex.com/astro/j.php?ED=117046192&RG=1&UID=0&RT=MiM3
News briefing 4
When: Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
• Shorter radiation course stops cancer growth in high-risk prostate cancer
patients.
• Shorter radiation course as effective as standard therapy for prostate cancer recurrence.
Where: McCormick Place West, Room 176b/c, or on the Web at https://astro.webex.com/astro/j.php?ED=117047452&RG=1&UID=0&RT=MiM3
How: To participate in the webcasts, click on the links above to view slides and listen to the audio of the conference live over the Internet.
Contact: Call the ASTRO Press Room at 312-791-7005 from November 1-4, or e-mail Beth Bukata at bethb@astro.org or Nicole Napoli at nicolen@astro.org. After hours, please call 703-474-0940.
###
Beth Bukata
Assistant Director of Communications
American Society for Radiation Oncology
Fairfax, VA
703-839-7332
